1. What is Deca Durabolin?

Deca Durabolin is formulated as a solution with a concentration of 50 mg/ml. Its main active ingredient is Nandrolone, which belongs to the group of long-acting anabolic steroids. These are synthetic compounds chemically related to testosterone, with more anabolic effects and fewer androgenic effects. However, androgenic effects can still occur, and higher doses or longer treatment duration can increase the risk of masculinization.

Nandrolone has been shown to increase calcium metabolism, as evidenced by increased urinary calcium excretion. Increased bone mass has been observed in postmenopausal women with osteoporosis during treatment. It also has a nitrogen-sparing effect and influences protein metabolism. At high doses, it can stimulate bone marrow, leading to increased red blood cell production.

2. Indications for Deca Durabolin

• Treatment of severe osteoporosis with clinical manifestations in postmenopausal women.
• Osteoporosis diagnosed based on compression fractures of the vertebrae or fractures in other bones.
• Reduced bone mineral density identified using recognized Bone Mineral Density Tests.
• Anemia due to chronic kidney failure.
• Aplastic anemia.

3. Contraindications for Deca Durabolin

• Patients with prostate cancer or male breast cancer.
• Hypersensitivity to the active ingredient or excipients, including peanut oil.
• Pregnant women or breastfeeding women.

4. Dosage and Administration of Deca Durabolin

Administration: Deca Durabolin is administered via deep intramuscular injection.

Dosage:

• Postmenopausal osteoporosis: 50 mg once every 3 weeks.
• Anemia due to chronic kidney failure: Women: 100 mg once a week; Men: 200 mg once a week.
• Aplastic anemia: 50–100 mg once a week. Periodic monitoring is necessary to decide whether to continue or discontinue treatment based on therapeutic outcomes.

If a patient does not show a complete response after 3–6 months of treatment, therapy should be discontinued. After the red blood cell count returns to normal, the dosage should be gradually reduced based on hematological test results. In case of relapse, retreatment can be considered. Severe cases of aplastic anemia may not respond.

For children: There is limited data on use in children. Extreme caution and close monitoring are required. The above dosages are for reference only; the specific dosage depends on the patient’s condition and must be determined by a healthcare professional.

5. Side Effects of Using Deca Durabolin

• Benign prostatic hypertrophy.
• Signs of virilization (some may be irreversible).
• Increased libido.
• Hypertension (high blood pressure).
• Voice changes or disturbances.
• Gastrointestinal disturbances (nausea, vomiting, abdominal pain).
• Mild liver dysfunction reported, especially with high doses.
• Acne, hirsutism, rash, hair loss, itching.
• Premature and irreversible epiphyseal closure, muscle pain, joint pain.
• Clitoris/penis enlargement, oligomenorrhea, amenorrhea, sperm suppression, priapism, urinary retention.
• Injection site pain, swelling, hematoma, or edema.
• Lab effects: decreased HDL; increased lipids, glucose, hemoglobin, hematocrit, urinary 17-ketosteroids.
• Long-term high-dose use may reduce glucose tolerance, cause mental disturbances, insomnia, and aggressive behavior.

If any adverse reactions occur, discontinue the medication and seek medical attention immediately.